Enhancer of zeste homolog 2 (EZH2) regulates gene expression and plays a definite role in
cell proliferation, apoptosis, and senescence. Overexpression of EZH2 has been found in …

Gastric cancer (GC) remains one of the deadliest malignancies worldwide, demanding new
targets to improve its diagnosis and treatment. Long non-coding RNAs (lncRNAs) are …

Diffuse-type gastric adenocarcinoma (DGAC) is a deadly cancer often diagnosed late and
resistant to treatment. While hereditary DGAC is linked to CDH1 mutations, the role of …

Gastrointestinal (GI) cancers have been considered primarily genetic malignancies, caused
by a series of progressive genetic alterations. Accumulating evidence shows that histone …

Histone lysine methyltransferase SUV4-20H2, a member of the suppressor of variegation 4–
20 homolog (SUV4-20) family, has a critical impact on the regulation of chromatin structure …

Simple Summary Histone and DNA methylations are widely studied epigenetic marks in
gastric cancer. Methylation is involved in DNA damage repair (DDR) and can also regulate …

Background: Stomach adenocarcinoma (STAD) is the fifth most common cancer and the
third leading cause of cancer-related deaths worldwide. Cancer-testis antigens (CTAs) …

Gastric cancer continues to have a high death rate despite advancements in their diagnosis
and treatment. Novel treatment techniques are thus desperately needed. This is where …

Gastrointestinal (GI) cancers are some of the main public health threats to the world. Even
though surgery, chemotherapy, and targeted therapy are available for their treatments, these …

To investigate the impact of hyperglycemia on the prognosis of patients with gastric cancer
and identify key molecules associated with high glucose levels in gastric cancer …